|
Market Closed -
NYSE
16:00:02 2026-08-21 EDT
|
5-day change | 1st Jan Change | ||
| 93.02 USD | -0.67% |
|
-2.07% | +17.21% |
| 08-19 | Argus Adjusts Price Target on CVS Health to $114 From $104, Keeps Buy Rating | MT |
| 08-17 | CVS Health Names JPMorgan's Heitsenrether to Board | MT |
| Market Cap | 120B 103B 95.92B 87.81B 165B 11,461B 167B 1,133B 442B 5,753B 450B 440B 19,028B | P/E 2026 * |
13.8x | P/E 2027 * | 13.2x |
|---|---|---|---|---|---|
| Enterprise Value | 172B 147B 137B 126B 236B 16,428B 239B 1,625B 633B 8,247B 645B 631B 27,275B | EV / Sales 2026 * |
0.41x | EV / Sales 2027 * | 0.39x |
| Free-Float |
71.17% | Yield 2026 * |
2.84% | Yield 2027 * | 2.92% |
Last Transcript: CVS Health Corporation
| 1 day | -0.67% | ||
| 1 week | -2.07% | ||
| Current month | -10.93% | ||
| 1 month | -13.56% | ||
| 3 months | -0.28% | ||
| 6 months | +21.29% | ||
| Current year | +17.21% |
| 1 week | 92.35 |  | 96.5 |
| 1 month | 92.35 | | 110.68 |
| Current year | 69.51 | | 110.68 |
| 1 year | 69.51 | | 110.68 |
| 3 years | 43.56 | | 110.68 |
| 5 years | 43.56 | | 111.25 |
| 10 years | 43.56 | | 111.25 |
| Manager | Title | Age | Since |
|---|---|---|---|
J. Joyner
CEO | Chief Executive Officer | 62 | 2024-10-16 |
Ali Keshavarz
PSD | President | - | - |
Brian Newman
DFI | Director of Finance/CFO | 57 | 2025-05-11 |
| Director | Title | Age | Since |
|---|---|---|---|
C. Brown
BRD | Director/Board Member | 74 | 2007-02-28 |
Anne Finucane
BRD | Director/Board Member | 73 | 2011-01-19 |
| Director/Board Member | 71 | 2015-03-04 |
| Date | Insider | Type | Main position | Quantity | % Market Cap. | |
|---|---|---|---|---|---|---|
| 5/14/26 | Free | Director | 1,737 | 0.0001% | ||
| 2/28/26 | Tax | Executive/Senior Manager | 7,886 | 0.0006% | ||
| 2/28/26 | Tax | Chief Executive Officer | 1,944 | 0.0002% |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | -0.67% | -2.07% | +31.35% | +39.23% | 120B | |
| +5.64% | +4.24% | +4.63% | +59.53% | 87.96B | |
| +1.28% | +3.54% | +32.53% | +83.06% | 26.63B | |
| -0.25% | +4.12% | -3.88% | -9.17% | 22.17B | |
| +3.00% | +5.14% | +54.32% | +297.24% | 21.95B | |
| +1.48% | +1.75% | -8.03% | +14.24% | 14.2B | |
| -1.83% | -2.07% | -7.32% | -9.94% | 12.66B | |
| -0.81% | -2.99% | +26.49% | +71.15% | 11.18B | |
| -1.74% | +8.46% | +127.42% | +2,036.36% | 9.88B | |
| +2.54% | +3.53% | -4.03% | +37.88% | 10.19B | |
| Average | +0.86% | -0.41% | +25.35% | +261.96% | 33.66B | |
| Weighted average by Cap. | +1.51% | -0.59% | +22.11% | +118.39% |
| 2026 * | 2027 * | |
|---|---|---|
| Net sales | 418B 358B 335B 306B 575B 39,970B 583B 3,953B 1,541B 20,065B 1,568B 1,534B 66,361B | 430B 368B 344B 315B 591B 41,109B 599B 4,065B 1,585B 20,637B 1,613B 1,578B 68,252B |
| Net income | 8.8B 7.53B 7.05B 6.45B 12.11B 842B 12.27B 83.25B 32.45B 423B 33.03B 32.31B 1,398B | 9.1B 7.8B 7.29B 6.67B 12.53B 871B 12.7B 86.14B 33.58B 437B 34.18B 33.43B 1,446B |
| Net Debt | 51.92B 44.46B 41.58B 38.06B 71.45B 4,968B 72.42B 491B 191B 2,494B 195B 191B 8,247B | 49.15B 42.08B 39.36B 36.03B 67.64B 4,703B 68.55B 465B 181B 2,361B 185B 180B 7,807B |
| Date | Price | Change | Volume |
|---|---|---|---|
| 26-08-21 | US$93.02 | -0.67% | 5,588,285 |
| 26-08-20 | US$93.65 | 0.00% | 6,439,680 |
| 26-08-19 | US$93.65 | -1.33% | 6,351,620 |
| 26-08-18 | US$94.91 | +0.96% | 6,855,122 |
| 26-08-17 | US$94.01 | -3.24% | 7,298,832 |
Trader
This super rating is the result of a weighted average of the rankings based on the following ratings: Valuation (Composite), EPS Revisions (4 months), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Investor
This super composite rating is the result of a weighted average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), EPS Revisions (1 year), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Global
This composite rating is the result of an average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), Financial Estimates Revisions (Composite), Consensus (Composite) and Visibility (Composite). The company must be covered by at least 4 of these 5 ratings for the calculation to be carried out. We recommend that you carefully review the associated descriptions.
Quality
This composite rating is the result of an average of rankings based on the following ratings: Returns (Composite), Profitability (Composite) and Quality of Financial Reporting (Composite), and Financial Health (Composite). The company must be covered by at least 2 of these 3 ratings for the calculation to be performed. We recommend that you carefully read the associated descriptions.
ESG MSCI
The MSCI ESG score assesses a company’s environmental, social, and governance practices relative to its industry peers. Companies are rated from CCC (laggard) to AAA (leader). This rating helps investors incorporate sustainability risks and opportunities into their investment decisions.
Quarterly revenue - Rate of surprise
- Stock Market
- Stocks
- CVS Stock
Select your edition
All financial news and data tailored to specific country editions
